ReviewAnnals of gastroenterology2025
Radiological biliary intervention for stone disease.
Review in Annals of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gallstones are primarily crystalline cholesterol formations that may present significant medical concerns, often leading to bile duct obstruction. Their genesis is multifaceted, influenced by genetics, diet and age. Over the decades, the biliary stone management domain has undergone a transformation, propelled by clinical demands and technological advances. This review focuses on percutaneous treatments, highlighting the shift from foundational percutaneous transhepatic cholangiography to advanced percutaneous transhepatic cholangioscopy, emphasizing patient safety, efficacy, and outcomes. The significance of patient-reported outcomes, capturing aspects that include pain and post-intervention quality of life, is accentuated. A critical analysis reveals a gap in our understanding of the long-term resilience of percutaneous interventions, particularly with respect to averting stone recurrence or treating chronic strictures. The potential of technological enhancements, including advanced endoscopes and real-time imaging, is acknowledged, though the need for rigorous clinical validation must be stressed. Decision-making challenges, due to the myriads of available interventions, are highlighted, emphasizing the need for evidence-based algorithms. Economically, the cost dynamics, both direct and ancillary, of these interventions come to the forefront. Concluding, the paper advocates for continuous innovation, ensuring that biliary stone management remains efficient, patient-centered, safe, and economically justified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.